Skip to content

Soy Fiber Improves Weight Loss and Lipid Profile

Soy Fiber Improves Weight Loss And Lipid Profile In Overweight And Obese Adults: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01802840
Enrollment
39
Registered
2013-03-01
Start date
2012-03-31
Completion date
2012-07-31
Last updated
2022-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight, Weight Loss

Brief summary

The aim of this study is to examine the effects of soy fiber on body weight, body composition and blood lipids in overweight and obese participants.

Detailed description

Thirty nine overweight and obese college adults (19-39 y of age) were randomly assigned to consume control biscuits or biscuits supplemented with soy fiber for 12 wk (approximately 100g/d). Information on body weight, body mass index, waist/hip circumference, blood pressure as well as measures of lipoprotein, glucose concentrations, and HbA1c was obtained at baseline, 8 and 12 wk after intervention. Body composition was also assessed at baseline and wk 12, respectively.

Interventions

DIETARY_SUPPLEMENTbiscuits supplemented with soy fiber

Thirty nine overweight and obese college adults (19-39 y of age) were randomly assigned to consume control biscuits or biscuits supplemented with soy fiber for 12 wk (approximately 100g/d).

Sponsors

Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* BMI of 23-35 kg/m2

Exclusion criteria

* Subjects taking any drugs, botanicals or nutraceutical known to influence body weight or blood pressure * significant history of eating disorders * strenuous exercise to lose weight * lipid-lowering medication * use of steroids and other agents that may influence lipid metabolism * hyperlipidemia * hyperglycemia * diabetes mellitus * cardiovascular disease * major systemic diseases * gastrointestinal problems * liver and renal failure

Design outcomes

Primary

MeasureTime frameDescription
weight loss12 weeksBody weight of participants in soy fiber group was decreased significantly over the study period compared with the baseline.

Secondary

MeasureTime frameDescription
serum levels of total cholesterol12 weeksSerum levels of total cholesterol of participants in soy fiber group was decreased significantly over the study period compared with the baseline.
serum levels of low density lipoprotein cholesterol12 weeksSerum levels of low density lipoprotein cholesterol of participants in soy fiber group was decreased significantly over the study period compared with the baseline.
body fat12 weeksBody fat of participants in soy fiber group was lowered significantly at wk 12 than that of baseline.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026